| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...990411K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0090411 |
| P8608 | Fatcat ID | release_qskc2gegdrhvddytpkwj7wmyla |
| P932 | PMC publication ID | 3940871 |
| P698 | PubMed publication ID | 24594764 |
| P5875 | ResearchGate publication ID | 260525800 |
| P2093 | author name string | Sanjay Chhibber | |
| Sandeep Kaur | |||
| Kusum Harjai | |||
| P2860 | cites work | Biofilms: microbial life on surfaces | Q22305656 |
| Bacteriophage therapy | Q24550616 | ||
| Antibiotic resistance of bacteria in biofilms | Q28207706 | ||
| Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics | Q28390950 | ||
| The future of biologic coatings for orthopaedic implants | Q28394906 | ||
| Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings | Q30796517 | ||
| Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression | Q33197091 | ||
| Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release | Q33232086 | ||
| Phage therapy: past history and future prospects | Q33799004 | ||
| Bacteriophages: potential treatment for bacterial infections | Q34120000 | ||
| Linezolid: the first oxazolidinone antimicrobial | Q34170643 | ||
| Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci | Q34229917 | ||
| New developments in diagnosis and treatment of infection in orthopedic implants | Q34326492 | ||
| Linezolid for the treatment of drug-resistant infections | Q34894133 | ||
| Immobilized antibiotics to prevent orthopaedic implant infections | Q36146837 | ||
| Biofilm in implant infections: its production and regulation. | Q36341333 | ||
| Phage therapy: facts and fiction | Q36372770 | ||
| Infections associated with orthopedic implants | Q36521170 | ||
| The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus | Q36779557 | ||
| Periprosthetic joint infection: the incidence, timing, and predisposing factors | Q36826266 | ||
| Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. | Q50993487 | ||
| Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. | Q51179771 | ||
| Bacteriophages as therapeutic agents. | Q53462033 | ||
| Probing the mechanisms of drug release from hydroxypropylmethyl cellulose matrices | Q72543090 | ||
| Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves | Q73787749 | ||
| Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus | Q79453357 | ||
| Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement | Q80798479 | ||
| [Biological coating of implants in trauma and orthopedic surgery] | Q81384449 | ||
| Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation | Q84575997 | ||
| Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055 | Q85238141 | ||
| Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains | Q37156698 | ||
| Phage therapy pharmacology. | Q37705522 | ||
| Bacteriophages as potential new therapeutics to replace or supplement antibiotics | Q37784558 | ||
| Analysis of antibiotic resistance regions in Gram-negative bacteria | Q37874671 | ||
| Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy | Q37982066 | ||
| Treatment of osteomyelitis with a biodegradable antibiotic implant. | Q38556570 | ||
| In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus | Q39730651 | ||
| Pros and cons of phage therapy | Q41083979 | ||
| Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance | Q41816188 | ||
| Stabilization of bacteriophage during freeze drying | Q43182777 | ||
| Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. | Q43592286 | ||
| Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement | Q44049240 | ||
| Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid | Q44198687 | ||
| Linezolid penetration into osteo-articular tissues | Q44198710 | ||
| Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology | Q44342523 | ||
| Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model | Q44405727 | ||
| Determination of silver in blood, urine, and tissues of volunteers and burn patients | Q44662061 | ||
| Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery | Q45017473 | ||
| Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors | Q45722453 | ||
| Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia | Q46425775 | ||
| The use of phages for the removal of infectious biofilms | Q46437715 | ||
| Lysogeny and bacteriophage host range within the Burkholderia cepacia complex | Q47911814 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bacteriophage | Q165028 |
| Staphylococcus aureus | Q188121 | ||
| linezolid | Q411377 | ||
| P304 | page(s) | e90411 | |
| P577 | publication date | 2014-03-03 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization | |
| P478 | volume | 9 |
| Q40161010 | Beyond antibiotic therapy - Future antiinfective strategies - Update 2017 |
| Q61796059 | Fibrin glue as a local drug-delivery system for bacteriophage PA5 |
| Q36059113 | In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections |
| Q54950902 | Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection. |
| Q90473947 | Nonconventional Therapeutics against Staphylococcus aureus |
| Q90720289 | Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy? |
| Q35235414 | Scaffold-based anti-infection strategies in bone repair |
Search more.